Similar articles

• Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis: a rebuttal.

  Besseling J, Hutten BA, Meijers JC, Trip MD, Hovingh GK. Besseling J, et al. J Thromb Haemost. 2013 Sep;11(9):1787-8. doi: 10.1111/jth.12337. J Thromb Haemost. 2013. PMID: 23809272 No abstract available.
• Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.

  Adams NB, Lutsey PL, Folsom AR, Herrington DH, Sibley CT, Zakai NA, Ades S, Burke GL, Cushman M. Adams NB, et al. J Thromb Haemost. 2013 Jun;11(6):1078-84. doi: 10.1111/jth.12223. J Thromb Haemost. 2013. PMID: 23565981 Free PMC article.
• Effects of HMG-CoA reductase inhibitor on hemostasis.

  Koh KK. Koh KK. Int J Cardiol. 2000 Oct;76(1):23-32. doi: 10.1016/s0167-5273(00)00325-9. Int J Cardiol. 2000. PMID: 11121593 Review.
• The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA).

  Cainzos-Achirica M, Enjuanes C, Greenland P, McEvoy JW, Cushman M, Dardari Z, Nasir K, Budoff MJ, Al-Mallah MH, Yeboah J, Miedema MD, Blumenthal RS, Comin-Colet J, Blaha MJ. Cainzos-Achirica M, et al. Atherosclerosis. 2018 Nov;278:217-225. doi: 10.1016/j.atherosclerosis.2018.09.034. Epub 2018 Oct 4. Atherosclerosis. 2018. PMID: 30312930
• [Statin and cardiovascular diseases after 75 years].

  Retornaz F, Beliard S, Gremeaux E, Chiche L, Lagarde L, Andrianasolo M, Molines C, Oliver C. Retornaz F, et al. Rev Med Interne. 2016 Sep;37(9):625-31. doi: 10.1016/j.revmed.2016.06.001. Epub 2016 Jul 4. Rev Med Interne. 2016. PMID: 27389014 Review. French.